SPONSORED CONTENT
Apexus remarked in October 2023, “It’s no longer a question of whether you’ll be audited; it’s a matter of when.” In the present 340B program climate, this assertion could apply to more than just HRSA audits.
…Month: August 2024
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Health Resources and Services Administration (HRSA) held a webinar yesterday to guide hospitals through their annual 340B recertification period, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
More than two-thirds of 340B contract pharmacies are associated with pharmacy benefit managers (PBMs) through either vertical integration or contractual [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A recent opinion piece published in JAMA is calling for significant reforms to the 340B program, including more provider transparency, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
With the annual 340B hospital recertification period occurring Aug. 12 to Sept. 9, the Health Resources and Services Administration’s (HRSA’s) [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
The 340B program is designed to help healthcare providers serving vulnerable populations stretch scarce resources as far as possible. In the face of increasing manufacturer restrictions, it is crucial for safety-net providers to explore various strategies to maintain financial sustainability. One of the
…
The Senate panel responsible for federal appropriations legislation overwhelmingly passed a bill last week that would increase funding for the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Pharmaceutical manufacturers Sanofi, GlaxoSmithKline (GSK) and Viatris are fully or partially exempting additional states from their 340B contract pharmacy restrictions. [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Novartis is now the third drug manufacturer to challenge Kansas’ new law prohibiting drug manufacturers from restricting contract pharmacy access [...] …